Sep 3, 2020   SOURCE: BusinessWire

Global High Throughput Screening Industry to 2024 - Featuring Beckman Coulter, Becton & Corning Among Others - ResearchAndMarkets.com

The "Global High Throughput Screening (HTS) Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

The high throughput screening market is poised to grow by $ 15.03 billion during 2020-2024 progressing at a CAGR of 12% during the forecast period.

The report on the high throughput screening market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rise in R&D investments, increasing prevalence of chronic disease, and patent expiration of drugs.

The high throughput screening market analysis includes end-user segment and geographic landscapes. This study identifies the increasing prevalence of chronic disease as one of the prime reasons driving the high throughput screening market growth during the next few years.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

Companies Mentioned

  • Agilent Technologies Inc.
  • AstraZeneca Plc
  • Beckman Coulter Inc.
  • Becton
  • Dickinson and Co.
  • Bio-Rad Laboratories Inc.
  • Charles River Laboratories International Inc.
  • Corning Inc.
  • Danaher Corp.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • PerkinElmer Inc.
  • Sartorius AG
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.

The high throughput screening market covers the following areas:

  • High throughput screening market sizing
  • High throughput screening market forecast
  • High throughput screening market industry analysis

Key Topics Covered:

1. Executive Summary

  • Market Overview

2. Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

3. Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

4. Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

5. Market Segmentation by End-user

  • Market segments
  • Comparison by End-user
  • Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024
  • Academic and research institutes - Market size and forecast 2019-2024
  • CROs - Market size and forecast 2019-2024
  • Market opportunity by End-user

6. Customer landscape

7. Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

8. Vendor Landscape

  • Competitive scenario
  • Vendor landscape
  • Landscape disruption
  • Industry risks

9. Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • AstraZeneca Plc
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Charles River Laboratories International Inc.
  • Corning Inc.
  • Danaher Corp.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • PerkinElmer Inc.
  • Sartorius AG
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.

10. Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/7fxuq3